Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

52-Week Prospective Randomized, Double-Blind Placebo-Controlled Safety and Efficacy Study of 2 Dosages of Botulinum Toxin Type-A Treatment for Primary Axillary Hyperhidrosis
158
Authors/Disclosures
Chike Ilorah, MD, MPH (Brookwood Baptist Health) No disclosure on file
Erik Z. Krause, DO (Ascension Medical Group) No disclosure on file
Brandon Bond, MD (OSF Healthcare) No disclosure on file
No disclosure on file
Jorge C. Kattah, MD, FAAN (University of Illinois College of Medicine at Peoria) Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm.
Bahareh Hassanzadeh, MD (Orlando Health) Dr. Hassanzadeh has nothing to disclose.
Irene C. Cortese, MD Dr. Cortese has stock in Keires, AG. Dr. Cortese has stock in Nouscom, AG. Dr. Cortese has stock in PDC Pharma. Dr. Cortese has a non-compensated relationship as a scientific advisor with Cellevolve that is relevant to AAN interests or activities.